Literature DB >> 17521370

Janus kinase 3-deficient T lymphocytes have an intrinsic defect in CCR7-mediated homing to peripheral lymphoid organs.

Eduardo A García-Zepeda1, Ileana Licona-Limón, M Fernanda Jiménez-Sólomon, Gloria Soldevila.   

Abstract

Chemokine-mediated signalling involves the activation of a Janus kinase (Jak) pathway. We have previously shown that Jak3 mediates CCR9 and CXCR4 signalling in response to CCL25 and CXCL12 in BM progenitors and thymocytes. The lack of peripheral lymph nodes and Peyer's patches observed in Jak3(-/-) mice suggested a possible role of Jak3 in CCR7-mediated homing to these organs. Here, we demonstrate phosphorylation of Jak3 in peripheral lymphocytes in response CCL19 and CCL21. In addition, Jak3(-/-) naïve T cells and pharmacologically inhibited Jak3(+/+) T lymphocytes have impaired chemotactic responses towards these ligands. Interestingly, CCR7 expression was higher in Jak3(-/-) thymocytes compared to their Jak3(+)(/-) littermates, indicating that the impaired migration must be caused by impaired CCR7-mediated signalling, in the absence of Jak3. In addition, adoptive transfer experiments showed that Jak3(+/+) mice reconstituted with Jak3(-/-) green fluorescent protein (GFP)(+) bone marrow progenitors had reduced T-lymphocyte homing to peripheral and mesenteric lymph nodes, compared to reconstitution with Jak3(+/+) GFP(+) progenitors. Furthermore, reciprocal transfer experiments indicated that Jak3(-/-) stromal cells were not responsible for the deficient T-cell homing. Finally, we performed direct competitive homing assays and demonstrated that Jak3(-/-) T lymphocytes have a clear defect in homing to peripheral and mesenteric lymph nodes, while migration to spleen was moderately impaired. Our data demonstrates that Jak3(-/-) T lymphocytes have an intrinsic defect in CCR7-mediated homing to peripheral lymphoid organs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17521370      PMCID: PMC2266000          DOI: 10.1111/j.1365-2567.2007.02634.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  61 in total

Review 1.  Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression.

Authors:  F Sallusto; A Lanzavecchia
Journal:  Immunol Rev       Date:  2000-10       Impact factor: 12.988

Review 2.  Leukocyte migration: scent of the T zone.

Authors:  J G Cyster
Journal:  Curr Biol       Date:  2000-01-13       Impact factor: 10.834

3.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

Review 4.  Role of chemokines in thymocyte development.

Authors:  A M Norment; M J Bevan
Journal:  Semin Immunol       Date:  2000-10       Impact factor: 11.130

5.  Chemokines define distinct microenvironments in the developing thymus.

Authors:  C C Bleul; T Boehm
Journal:  Eur J Immunol       Date:  2000-12       Impact factor: 5.532

6.  Janus kinase 3 (Jak3) is essential for common cytokine receptor gamma chain (gamma(c))-dependent signaling: comparative analysis of gamma(c), Jak3, and gamma(c) and Jak3 double-deficient mice.

Authors:  K Suzuki; H Nakajima; Y Saito; T Saito; W J Leonard; I Iwamoto
Journal:  Int Immunol       Date:  2000-02       Impact factor: 4.823

7.  Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues.

Authors:  Gudrun F Debes; Carrie N Arnold; Alan J Young; Stefan Krautwald; Martin Lipp; John B Hay; Eugene C Butcher
Journal:  Nat Immunol       Date:  2005-08-14       Impact factor: 25.606

Review 8.  The Jak-STAT pathway.

Authors:  K Imada; W J Leonard
Journal:  Mol Immunol       Date:  2000 Jan-Feb       Impact factor: 4.407

9.  Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse.

Authors:  S A Luther; H L Tang; P L Hyman; A G Farr; J G Cyster
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

10.  A profound deficiency in thymic progenitor cells in mice lacking Jak3.

Authors:  A M Baird; J A Lucas; L J Berg
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

View more
  7 in total

1.  Jak3 is involved in CCR7-dependent migration and invasion in metastatic squamous cell carcinoma of the head and neck.

Authors:  Zhongti Zhang; Fayu Liu; Zhenning Li; Dan Wang; Ruiwu Li; Changfu Sun
Journal:  Oncol Lett       Date:  2017-03-14       Impact factor: 2.967

2.  Jak3 enables chemokine-dependent actin cytoskeleton reorganization by regulating cofilin and Rac/Rhoa GTPases activation.

Authors:  Xochitl Ambriz-Peña; Eduardo Alberto García-Zepeda; Isaura Meza; Gloria Soldevila
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

3.  A Key Role for Inhibins in Dendritic Cell Maturation and Function.

Authors:  Roxana Olguín-Alor; Marisol de la Fuente-Granada; Laura C Bonifaz; Laura Antonio-Herrera; Eduardo A García-Zepeda; Gloria Soldevila
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

Review 4.  Bidirectional Regulation of Opioid and Chemokine Function.

Authors:  Thomas J Rogers
Journal:  Front Immunol       Date:  2020-01-31       Impact factor: 7.561

5.  Jak3 is involved in dendritic cell maturation and CCR7-dependent migration.

Authors:  Ana Rivas-Caicedo; Gloria Soldevila; Teresa I Fortoul; Andrés Castell-Rodríguez; Leopoldo Flores-Romo; Eduardo A García-Zepeda
Journal:  PLoS One       Date:  2009-09-17       Impact factor: 3.240

6.  JAK tyrosine kinases promote hierarchical activation of Rho and Rap modules of integrin activation.

Authors:  Alessio Montresor; Matteo Bolomini-Vittori; Lara Toffali; Barbara Rossi; Gabriela Constantin; Carlo Laudanna
Journal:  J Cell Biol       Date:  2013-12-23       Impact factor: 10.539

7.  IL-23 signaling regulation of pro-inflammatory T-cell migration uncovered by phosphoproteomics.

Authors:  Candelas Álvarez-Salamero; Raquel Castillo-González; Gloria Pastor-Fernández; Isabel R Mariblanca; Jesús Pino; Danay Cibrian; María N Navarro
Journal:  PLoS Biol       Date:  2020-03-23       Impact factor: 8.029

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.